Barclays Maintains an 'Overweight' on Riverbed Technology (RVBD); Weak EMEA Leads to Show Me Story

Barclays maintains an 'Overweight' on Riverbed Technology (NASDAQ: RVBD), PT $38.

Barclays analyst says, "Weakness ex US drove sales miss - despite expectations for a beat: We lower our EPS and price target modestly, given weakness in the EMEA region as well as higher opex from announced acquisitions...Estimates trimmed despite deals: Our new 2011/2012 estimates are $0.88/$1.15 from $0.91/$1.20. 2012 EPS assumes 27% sales growth and 29% margins. Our price target decreases modestly to $38 (33x CY12E EPS of $1.15). We estimate upside to $1.35."

Kvaal Call: Two uninspired quarters leaves RVBD a show me story for now. The 50% US growth suggests that RVBD will ultimately deliver internationally as well.

For more ratings news on Riverbed Technology click here and for the rating history of Riverbed Technology click here.

Shares of Riverbed Technology closed at $41.40 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Canaccord Downgrades York Space Systems (YSS) to Hold, 'Supply chain and contract timing uncertainty'
• BWS Financial Downgrades Inter Parfums (IPAR) to Sell
• Guggenheim Reiterates Buy Rating on EyePoint Inc. (EYPT)